Search results
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 3 days agoOverall, the jab has been linked to at least 81 fatalities and hundreds of injuries in the UK, and Dr Michael Head, a global health researcher at the...
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoOPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses...
Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 1 day agoThe intent is to position PRX-115 as a direct competitor in the market for uncontrolled gout patients. Q: How do the pharmacokinetic (PK) levels of PRX-115 trend over the observed three ...
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
Benzinga· 1 day agoFollowing the initial analysis up to Day 29 post-vaccination, the most recent analysis of study VLA1553-321 evaluated the safety and immunogenicity six months (Day 180) after vaccination with ...
A New Drug Is Helping Cervical Cancer Patients Live Longer
Verywell Health via Yahoo News· 6 days agoThe “full approval by the FDA reinforces the important role of Tivdak for these patients...and...
Earnings call: Enanta Pharmaceuticals Q2 fiscal results and pipeline updates By Investing.com
Investing.com· 7 days agoEnanta Pharmaceuticals (NASDAQ: NASDAQ:ENTA), a biopharmaceutical company focused on developing oral...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 4 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Q1 2024 Innovid Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoAs I mentioned earlier, we have a roadmap of Harmony products that will continue to be released throughout 2024. We believe Harmony will better balance the...
Regenxbio Inc (RGNX) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress and Robust ...
GuruFocus.com via Yahoo Finance· 5 days agoQ & A Highlights Q: What do you think the trial enrollment and regulatory implication, if any, from Pfizer's update yesterday for Duchenne Muscular Dystrophy (DMD)? A: Kenneth ...
Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights
GuruFocus.com via Yahoo Finance· 4 days agoThe anticipated mid-2024 pivotal readout of the Phase 3 AFFINE trial, a collaboration with Pfizer for hemophilia A treatment, could potentially lead to regulatory submissions ...